Welcome to our dedicated page for Naturl Alt Intl SEC filings (Ticker: NAII), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Natural Alternatives International, Inc. filings document the public-company record for a Nasdaq-listed Delaware nutritional supplement manufacturer. Recent 8-K reports describe material definitive agreements, credit-facility amendments, covenant waivers, officer employment and compensation arrangements, and principal financial-officer responsibilities.
Proxy and annual-meeting disclosures cover board elections, executive compensation votes, equity incentive plan amendments, auditor ratification, and shareholder voting results. Other filing exhibits document manufacturing agreements for customer nutritional products, revolving credit and term-loan arrangements, security interests, and governance matters affecting NAII common stock.
NATURAL ALTERNATIVES INTERNATIONAL INC CEO and Chairman Mark A. LeDoux reported open-market purchases of the company’s common stock. Over three days, he bought a total of 1,250 shares at prices ranging from $2.75 to $2.80 per share, increasing his direct ownership.
After these purchases, his directly held stake rose to 160,221 common shares. The filing also lists additional indirect holdings in the company’s stock through a family limited partnership, an IRA, and custodial accounts for family members, reflecting both personal and family-related ownership positions.
NATURAL ALTERNATIVES INTERNATIONAL INC CEO and Chairman Mark A. LeDoux reported open-market purchases of a total of 1,000 shares of common stock, buying 500 shares at $2.85 on February 27, 2026 and 500 shares at $2.79 on March 2, 2026. Following these trades, his directly held stake rose to 158,971 shares. The filing also lists additional indirect holdings in a family limited partnership, an IRA, and several custodial accounts as of February 27, 2026.
NATURAL ALTERNATIVES INTERNATIONAL INC CEO/Chairman and 10% owner Mark A. LeDoux reported buying additional common shares in the open market. On February 25–27, 2026, he made three open-market purchases totaling 1,250 shares at prices between $2.8000 and $2.8460 per share. After these transactions, his directly held stake rose to 157,971 common shares. He also reported indirect ownership positions held through the LeDoux Family Limited Partnership, an IRA, and several custodial accounts for family members, which are disclosed as separate indirect holdings.
Natural Alternatives International CEO and Chairman Mark A. LeDoux reported open-market purchases of company common stock. He bought 2,000 shares across three trades between February 20 and 24, 2026 at prices from $2.655 to $2.71 per share, increasing his direct holdings to 156,971 shares. He also reports indirect ownership positions through a family limited partnership, an IRA, and several custodial accounts, with updated share amounts for each as of February 20, 2026.
NATURAL ALTERNATIVES INTERNATIONAL INC CEO and Chairman Mark A. LeDoux reported open-market purchases of the company’s common stock. On February 19, he bought 1,500 shares at $2.555 per share, bringing his directly held stake to 154,721 shares afterward.
He also bought 500 shares at $2.563 per share on February 18 and 2,500 shares at $2.596 per share on February 17. The filing also lists indirect holdings, including 481,905 shares held by LeDoux Family Limited Partnership and additional shares held through an IRA and custodial accounts.
Natural Alternatives International reported modestly higher sales but ongoing losses for the quarter and six months ended December 31, 2025. Quarterly net sales rose to $34.8 million, with gross margin improving to 7.2% from 4.9% as factory utilization and mix improved.
Despite better margins, the company posted a quarterly net loss of $2.6 million (basic and diluted loss per share $0.42) and a six‑month net loss of $2.8 million, though the year‑to‑date loss narrowed versus the prior year. Private‑label manufacturing sales grew, while patent and trademark licensing revenue declined over six months.
Operating cash flow was weak: the business used $10.4 million of cash in the first half, driven by higher receivables and a sharp inventory build to $33.4 million. Cash and equivalents fell to $3.8 million, while borrowings included $5.8 million on a $10.0 million credit line and $8.8 million on a term loan.
The company disclosed non‑compliance with financial covenants on its Wells Fargo credit facility, received prior waivers, and is seeking further relief while also discussing a potential new asset‑based facility. Management now expects a net loss in the second half and for the full fiscal 2026 year.
Dimensional Fund Advisors LP filed an amended Schedule 13G reporting passive beneficial ownership of Natural Alternatives International Inc. common stock as of 12/31/2025. The filing shows beneficial ownership of 384,497 shares, representing 6.2% of the company’s common stock. Dimensional has sole power to vote 379,548 shares and sole power to dispose of 384,497 shares.
The shares are owned by various funds and accounts it advises, and Dimensional may be deemed a beneficial owner only for Section 13(d) purposes. The firm certifies the holdings are in the ordinary course of business and not for the purpose of changing or influencing control of Natural Alternatives International.
Natural Alternatives International, Inc. entered into a Waiver and Release Agreement with Wells Fargo Bank after breaching certain financial covenants in its existing credit agreement. For the fiscal first quarter ended September 30, 2025, the company did not comply with the maximum net loss and fixed charge coverage ratio requirements under its revolving and term loan facilities. On December 17, 2025, Wells Fargo agreed to waive all of these defaults and confirmed that the credit agreement, security agreement and related deed of trust remain in full force and effect, allowing NAI to maintain its current borrowing arrangements.
Natural Alternatives International, Inc. reported the results of its annual stockholder meeting held on December 5, 2025. Stockholders elected Class II director Alan G. Dunn to continue serving until the next Class II election and until his successor is elected and qualified.
Investors also approved the First Amendment to the 2020 Omnibus Equity Incentive Plan, allowing the company to continue using equity-based awards as part of its compensation programs. Stockholders ratified the selection of Haskell & White LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2026.
On executive pay matters, stockholders approved, on an advisory and non-binding basis, the compensation of the company’s named executive officers. In a separate advisory vote on the frequency of future say-on-pay votes, stockholders supported holding the vote every three years.
Natural Alternatives International, Inc. (NAII) filed its definitive proxy for the virtual Annual Meeting on December 5, 2025, at 11:00 a.m. PT. Stockholders will vote on six items, highlighted by an amendment to the 2020 Equity Incentive Plan to extend the term five years and increase shares authorized by 550,000 to 1,250,000.
The ballot includes: electing one Class II director (Alan G. Dunn); approving the equity plan amendment; ratifying Haskell & White LLP as auditor for fiscal year ending June 30, 2026; an advisory say‑on‑pay vote; and a say‑on‑frequency vote, with the Board recommending every three years. As of the October 13, 2025 record date, 6,176,778 shares of common stock were issued and outstanding. Directors and executive officers beneficially owned 1,282,782 shares (20.8%).
The company reports 158,877 shares remaining available under the current 2020 Plan and 541,123 shares granted and outstanding. Auditor fees were $249,000 in fiscal 2025. The meeting will be held exclusively online at https://meetnow.global/M25L7YJ, with electronic voting and Q&A available.